Acerus Pharmaceuticals Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 512,000 compared to USD 176,000 a year ago. Operating loss was USD 6.746 million compared to USD 5.050 million a year ago. Net loss was USD 7.070 million compared to USD 5.610 million a year ago. For the half year, negative total revenue was USD 5.458 million compared to total Revenue of USD 321,000 a year ago. Operating loss was USD 19.167 million compared to USD 9.305 million a year ago. Net loss was USD 19.896 million compared to USD 10.273 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.